MedReleaf, the Canadian medical marijuana company has filed to make its stock public. MedReleaf is one of the nation’s top cannabis producers, raking in around 10 million dollars annually. The company is one of the oldest in the Canadian medical marijuana field and has drawn attention to itself in recent years for advancements in consumer products and smart partnerships. With its IPO looming, all eyes are focused on what could become the largest cannabis company in the world.
Cannabis stocks are all the rage lately. News of Canadian legalization sent the top stocks soaring, and it doesn’t appear to be slowing anytime soon. Many wish they could go back and invest in corporate giants like Microsoft, Apple and Starbucks. A small investment then could have made millions, if only there was a time machine. Fortunately, you don’t need one. It doesn’t take a rocket scientist to figure out that once all impediments are stripped away, cannabis will genuinely be the next boom for not only those in involved, but for everyone. Investing in today’s medical marijuana, and soon to be recreational market, has the potential to bring newbie investors to the big leagues.
The two biggest medical marijuana companies based on stock valuations are GW Pharmaceuticals and Canopy Growth Corp. Together they have a valuation of over$4.1 billion, with GW leading the pack at $2.9B. MedReleaf has already demonstrated its ability to outsell the competition, beating out Canopy Growth in 2016 by over a million dollars. But what does this mean for MedReleaf’s IPO? Could they be the next billion dollar cannabis company? So far, all signs point to yes.
Late last year, the Toronto based producer announced that it was about to embark on a first for the medical marijuana market. In an effort to include patients who don’t feel comfortable smoking cannabis, MedReleaf developed a line of medical marijuana capsules that are just as effective as actually smoking. The company is growing internally at an exponential rate, as is evident by the recent announcement that they plan to hire 250 full-time employees and 100 part timers by the summer. They are hosting two job fairs coming up May 6th and 10th at the Bradford and District Community Centre which is sure to bring some attention to the growing company’s pending stock offering.
MedReleaf has garnered a reputation for providing quality medical marijuana and demonstrating solid business sense. The coming IPO is a culmination of years of hard work, not only in changing the industry, but in changing the minds of those who may once have been skeptical about marijuana’s success in the medical field. Their past accomplishments coupled with their seemingly solid vision for the future makes MedReleaf a stock worth adding to your portfolio.
Cory Hughes is a former police officer turned cannabis cultivator and writer. After years of being on the wrong side of the law, Cory decided to hang up his badge and gun and move into an industry that truly has the potential of bringing people together. He has been an active part of the Colorado cannabis culture and has worked as a horticulturist in dozens of licensed grow operations. Cory now looks to share his knowledge of cultivation and horticulture with the world.